The Joint Corp. (JYNT) Revenue History
The Joint Corp. (JYNT) annual and quarterly revenue history with charts. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $20.23M |
| 2017-12-31 | $24.92M |
| 2018-12-31 | $36.66M |
| 2019-12-31 | $48.45M |
| 2020-12-31 | $58.68M |
| 2021-12-31 | $80.86M |
| 2022-12-31 | $101.25M |
| 2023-12-31 | $46.98M |
| 2024-12-31 | $52.16M |
| 2025-12-31 | $54.90M |
How JYNT compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| NKTR | Nektar Therapeutics | $55.23M |
| AGIO | Agios Pharmaceuticals Inc. | $54.03M |
| OCUL | Ocular Therapeutix Inc. | $51.95M |
| LXRX | Lexicon Pharmaceuticals Inc. | $49.80M |
| GOSS | Gossamer Bio Inc. | $48.47M |
These are five companies in the same sector as JYNT with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get The Joint Corp. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("JYNT", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | JYNT | $8.68 | +1.05% | 0.06M |
| 3 | ||||
| 4 | ||||
| 5 |